New-age vaccine adjuvants: Friend or foe?

BioPharm International

Volumn 20, Issue 8 SUPPL., 2007, Pages 24-33

  Petrovsky, Nikolai ^a   Heinzel, Susanne ^b   Honda, Yoshikazu ^c   Lyons, A Bruce ^b,d  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c VAXINE PTY LTD   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT 65; ADVAX; ALUMINUM POTASSIUM SULFATE; CANCER VACCINE; CPG OLIGODEOXYNUCLEOTIDE; HEPATITIS B VACCINE; HERPES VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; HYDROCARBON OIL; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; ISA 720; ISCOM; LIPOSOME; LIPOVANT; MALARIA VACCINE; MONTANIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; PHOSPHORYL LIPID A; QS 21; SBAS 2; UNCLASSIFIED DRUG; VACCINE; WART VIRUS VACCINE; WATER OIL CREAM;

ABSCESS; ADJUVANT ARTHRITIS; ADJUVANT THERAPY; ALLERGIC REACTION; ANAPHYLAXIS; ARTHRITIS; CELLULAR IMMUNITY; CHILL; CHRONIC INFLAMMATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG RESEARCH; DRUG STABILITY; DRUG TOLERABILITY; EOSINOPHILIA; FATIGUE; FEVER; FLU LIKE SYNDROME; GRANULOMA; HEADACHE; HEMOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOTOXICITY; INFLAMATORY ARTHRITIS; INFLUENZA; INJECTION SITE INFLAMMATION; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE SWELLING; LYMPHADENOPATHY; MACROPHAGIC MYOFASCITIS; MALAISE; MALARIA; MONOTHERAPY; MYALGIA; NAUSEA; NONHUMAN; REVIEW; ULCER; UNSPECIFIED SIDE EFFECT; UVEITIS; VACCINE PRODUCTION; X RAY MICROANALYSIS;

EID: 34548203261     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)